Search

everythinglearnresearchcommunity

for

Search:↓

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Histone modification is key in treating chronic inflammatory skin diseases.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Some drugs used to treat immune conditions may cause different types of hair loss.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Gray hair can potentially be reversed, leading to new treatments.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.